Related Experiment Video
Updated: May 6, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
A degradative detour for mutant TP53
Helin Vakifahmetoglu-Norberg1, Junying Yuan
1Department of Cell Biology, Harvard Medical School, Boston, MA USA.
Abstract:
Accumulation of mutant TP53 proteins in cancer cells has been recognized as an important factor that promotes cancer progression and metastasis. Thus, strategies that promote the degradation of mutant TP53 might be beneficial for the treatment of cancers. In a recent issue of Genes & Development, we demonstrated that blocking macroautophagy under nutritional stress condition leads to the degradation of mutant TP53 through activating the chaperone-mediated autophagy (CMA) pathway in nonproliferating cancer cells. We propose CMA as a new degradative mechanism for mutant TP53 and the possibility of activating CMA as a new treatment for cancers with mutant TP53.
Insights
Blocking macroautophagy during nutritional stress degrades mutant TP53 via chaperone-mediated autophagy (CMA) in nonproliferating cancer cells. This suggests activating CMA as a novel cancer therapy targeting mutant TP53.
Area of Science:
- Oncology
- Molecular Biology
- Cellular Biology
Background:
- Mutant TP53 protein accumulation drives cancer progression and metastasis.
- Targeting mutant TP53 degradation presents a potential therapeutic strategy for cancer treatment.
Purpose of the Study:
- To investigate the role of macroautophagy inhibition in mutant TP53 degradation.
- To explore chaperone-mediated autophagy (CMA) as a mechanism for clearing mutant TP53.
- To assess the therapeutic potential of activating CMA for mutant TP53-driven cancers.
Main Methods:
- Cancer cells were subjected to nutritional stress.
- Macroautophagy was inhibited under these conditions.
- Chaperone-mediated autophagy (CMA) activation was monitored.
- Mutant TP53 protein levels were assessed.
Main Results:
- Inhibition of macroautophagy under nutritional stress induced mutant TP53 degradation.
- This degradation was mediated by the activation of the chaperone-mediated autophagy (CMA) pathway.
- The effect was observed in nonproliferating cancer cells.
Conclusions:
- Chaperone-mediated autophagy (CMA) represents a novel pathway for mutant TP53 degradation.
- Activating CMA could be a new therapeutic approach for cancers harboring mutant TP53.
- Targeting CMA offers a promising strategy for improving outcomes in specific cancer types.
More Related Videos
04:56Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
07:18Gene-targeted Random Mutagenesis to Select Heterochromatin-destabilizing Proteasome Mutants in Fission Yeast
Published on: May 15, 2018
Related Concept Videos
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
Restarting Stalled Replication Forks
Long-patch Base Excision Repair
DNA Damage can Stall the Cell Cycle